How do you pay?

How to pay the least

Cash price

$940+ for 30 tablets

Pharmacies pay about this for Sunosi; you’d pay more.

  1. Ask your pharmacy for Sunosi’s cash price, and one or two other pharmacies too.
  2. Sunosi’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameSunosi
Authorized genericsolriamfetol
Regular genericsolriamfetol
What you’d pay
At least$940for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Sunosi?
The original
–
–

Brand nameThe maker’s card

SUNOSI Savings Card

Savings card from Axsome Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $9 for a 90-day supply

Sign up on sunosi.com 

In the maker’s words

“Get up to 90 days of SUNOSI for as little as $9…”

From the maker’s offer on sunosi.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Sunosi itself, from the same company, sold without the brand name, and usually for less. For now Sunosi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SUNOSI is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).

Limitations of Use

SUNOSI is not indicated to treat the underlying airway obstruction in OSA. Ensure that the underlying airway obstruction is treated (e.g., with continuous positive airway pressure (CPAP)) for at least one month prior to initiating SUNOSI for excessive daytime sleepiness. Modalities to treat the underlying airway obstruction should be continued during treatment with SUNOSI. SUNOSI is not a substitute for these modalities.

Source: the FDA label for Sunosi (Axsome Therapeutics, Inc.), May 5, 2026. Full label on DailyMed 

Good to know